Skip to main content
Premium Trial:

Request an Annual Quote

BGI Acquires 27 SOLiD 4 Sequencers

Premium

This story was originally published Oct. 29.

Life Technologies said last week that China's BGI has acquired 27 SOLiD 4 systems, which will allow BGI to sequence 50 whole human genomes per month.

Li Jingxiang, vice president of genomics operations for BGI, said in a statement that the SOLiDs will enable the institute to "secure sequence data for a complete whole human genome on 30x coverage that includes 100 gigabases of mapped data at an accuracy of 99.9 percent."

The new SOLiDs will join a fleet of Illumina machines at BGI. In January, the institute ordered 128 HiSeq 2000 sequencers, which have been installed over the course of the year (IS 1/12/2010).

Paul Tu, president of BGI Americas, told In Sequence in September that by the end of the year, BGI's Hong Kong location will have at least 100 Illumina HiSeq 2000 machines and 20 SOLiD instruments, while BGI's Shenzhen facility will have 37 HiSeq 2000 instruments and between 5 and 10 SOLiD instruments.

Tu said at the time that the number of SOLiDs might grow, "depending on the customer demand in human resequencing." (IS 9/21/2010)

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.